Press release
Analog Devices and Flagship Pioneering Announce Strategic Partnership to Accelerate the Development of a Fully Digitized Biological World
Partnership will Leverage Complementary Expertise in Applied Biology and Engineering to Create and Enhance Multiple Digital Biology Platform Companies
About this update from Analog Devices, Inc.
[{"type":"text","content":"Partnership will Leverage Complementary Expertise in Applied Biology and Engineering to Create and Enhance Multiple Digital Biology Platform Companies\nWILMINGTON, Mass. and CAMBRIDGE, Mass., July 25, 2024 /PRNewswire/ -- Analog Devices, Inc. (Nasdaq: ADI), a global semiconductor leader, and Flagship Pioneering, the bioplatform innovation company, today announced a strategic alliance to accelerate the development of a fully digitized biological world. This partnership will bridge ADI's expertise in engineering for analog and digital semiconductors with Flagship Pioneering's expertise in applied biology to foster the discovery of biological insights, new and enhanced measurements, diagnostics, and novel interventions. The partnership represents the opportunity to create breakthrough solutions for human health and sustainability.\n\n \n \n \n \n \n \n\n \nSpecifically, the partnership will leverage Flagship Pioneering's unique innovation process and ADI's cutting edge semiconductor technologies, signal processing portfolio and physical world domain expertise to unlock deeply disruptive solutions and create new companies in the digital biology space. Initial areas of focus will include bioelectronic platforms, regenerative agriculture, novel applications of AI/ML, and preemptive health and medicine. Potential advancements may further drive next-generation protein sequencing, multiomics, early disease diagnostics, transformation of large biological information to actionable digital data, drug design and optimization, and more. This partnership is the latest in Flagship Pioneering's Enabling Technologies Initiative, which is focused on the development of new therapeutic modalities by enabling and powering advanced technologies.\n\"At its core, ADI exists to accelerate breakthroughs that enrich lives and the world around us,\" said Vincent Roche, CEO and Chair at ADI. \"Innovative technology has the potential to enable better and more proactive care. We expect our digital biology partnership with Flagship Pioneering will put the Intelligent Edge at the center of innovating data-informed health solutions for some of today's biggest challenges.\"\n\"Fueled by technological leaps and deep biological understanding, we have entered a new era of biomedical and life science innovation, enabling ever-greater advances to improve the health of ...